Cargando…
BNT162b2 COVID-19 Vaccine Induced Immune Thrombocytopenic Purpura
Immune thrombocytopenic purpura (ITP) has been reported following vaccinations such as MMR as well as after viral infections such as hepatitis C and HIV. Few case reports have been reported of ITP after COVID-19 infections and COVID-19 vaccines. Herein, we present a patient who presented with severe...
Autores principales: | Ghosh, A. K., Bhushan, S., Lopez, L. D. R., Sampat, D., Salah, Z., Hatoum, C. A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9019434/ https://www.ncbi.nlm.nih.gov/pubmed/35464782 http://dx.doi.org/10.1155/2022/5603919 |
Ejemplares similares
-
Immune-Mediated Thrombotic Thrombocytopenic Purpura after BNT162b2 Vaccine
por: Güney, Tekin, et al.
Publicado: (2022) -
Thrombotic thrombocytopenic purpura: a new menace after COVID bnt162b2 vaccine
por: Waqar, Syed Hamza Bin, et al.
Publicado: (2021) -
Acquired thrombotic thrombocytopenic purpura after first vaccination dose of BNT162b2 mRNA COVID-19 vaccine
por: Ruhe, Johannes, et al.
Publicado: (2021) -
Immune-Mediated Thrombotic Thrombocytopenic Purpura Following mRNA-Based COVID-19 Vaccine BNT162b2: Case Report and Mini-Review of the Literature
por: Buetler, Vanessa Alexandra, et al.
Publicado: (2022) -
A Case of Idiopathic Thrombocytopenic Purpura After Booster Dose of BNT162b2 (Pfizer-Biontech) COVID-19 Vaccine
por: Malayala, Srikrishna V, et al.
Publicado: (2021)